{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:07:41Z","timestamp":1762999661813,"version":"3.41.2"},"reference-count":95,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"received for this research"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2022,1,31]]},"DOI":"10.1080\/21645515.2020.1865774","type":"journal-article","created":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T04:13:04Z","timestamp":1612671184000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["Coronavirus (SARS-CoV-2): a systematic review for potential vaccines"],"prefix":"10.1080","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8850-7604","authenticated-orcid":false,"given":"Mihir","family":"Bhatta","sequence":"first","affiliation":[{"name":"ICMR-National Institute of Cholera and Enteric Diseases","place":["Kolkata, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srijita","family":"Nandi","sequence":"additional","affiliation":[{"name":"ICMR-National Institute of Cholera and Enteric Diseases","place":["Kolkata, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanta","family":"Dutta","sequence":"additional","affiliation":[{"name":"ICMR-National Institute of Cholera and Enteric Diseases","place":["Kolkata, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malay Kumar","family":"Saha","sequence":"additional","affiliation":[{"name":"ICMR-National Institute of Cholera and Enteric Diseases","place":["Kolkata, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-0695-z"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2002387"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30251-8"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr4241"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/03079450310001621198"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2006.12.016"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfms.2007.01.002"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2005.03.021"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-016-0430-6"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.2217\/fvl.12.126"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01781"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30266-X"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/490020a"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.2307\/1588476"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/220650b0"},{"key":"e_1_3_7_17_1","doi-asserted-by":"crossref","unstructured":"Tyrrell DA Fielder M. Cold Wars: the fight against the common cold. Oxford: Oxford University Press; 2002. p. 96. ISBN 0 19 263285 X","DOI":"10.1093\/oso\/9780192632852.001.0001"},{"key":"e_1_3_7_18_1","first-page":"149","volume-title":"Chapter 17 - family coronaviridae, viruses","author":"Payne S","year":"2017","unstructured":"Payne S. ed. Chapter 17 - family coronaviridae, viruses. USA: Academic Press; 2017. p. 149\u201358."},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2016.03.003"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-2438-7_1"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00135"},{"key":"e_1_3_7_22_1","volume-title":"Sanofi, GSK partner to develop adjuvanted COVID-19 vaccine","author":"McGrail S","year":"2020","unstructured":"McGrail S. Sanofi, GSK partner to develop adjuvanted COVID-19 vaccine. In: Murphy KS. Denvers: Pharma News Intelligence, Xtelligent Healthcare Media; 2020."},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-0695-z"},{"key":"e_1_3_7_24_1","doi-asserted-by":"crossref","unstructured":"World Health Organization timeline - COVID-19. World health organization. 27 April 2020","DOI":"10.15557\/PiMR.2020.0004"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.08.058"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1086\/427242"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1086\/500143"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14962-8"},{"key":"e_1_3_7_29_1","article-title":"Researchers rush to test coronavirus vaccine inpeople without knowing how well it works in animals","author":"Boodman E","year":"2020","unstructured":"Boodman E. Researchers rush to test coronavirus vaccine inpeople without knowing how well it works in animals. Boston: STAT. 2020. p. 1.","journal-title":"STAT"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb8923"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0323-4"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200678"},{"key":"e_1_3_7_33_1","first-page":"S1931","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","volume":"5","author":"Magro C","year":"2020","unstructured":"Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, Baxter-Stoltzfus A, Laurence J. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020;5:S1931\u2013S5244.","journal-title":"Transl Res"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00937"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00202"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2019.0098"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-020-00073\u20135"},{"key":"e_1_3_7_38_1","unstructured":"Lee CE Welker K Perlmutter-Gumbiner E. Health officials eyeing at least one of 14 potential coronavirus vaccines to fast-track. NBC News. 2020."},{"key":"e_1_3_7_39_1","unstructured":"COVID-19 treatment and vaccine tracker (PDF). Milken Institute."},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.13140\/RG.2.2.35948.10880"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/trstmh\/tru168"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.370.6519.895"},{"key":"e_1_3_7_43_1","doi-asserted-by":"crossref","unstructured":"Bacille Calmette-Gu\u00e9rin (BCG) vaccination and COVID-19. World health organization (WHO). April 2020.","DOI":"10.15557\/PiMR.2020.0025"},{"key":"e_1_3_7_44_1","unstructured":"EudraCT 2020-000919-69. EU clinical trials register."},{"key":"e_1_3_7_45_1","unstructured":"Murdoch Children\u2019s Research Institute to trial preventative vaccine for COVID-19 healthcare workers. Murdoch children\u2019s research institute."},{"key":"e_1_3_7_46_1","unstructured":"BCG Vaccination to Protect Healthcare Workers Against COVID-19. ClinicalTrials.gov."},{"key":"e_1_3_7_47_1","unstructured":"BCG Vaccine for Health Care Workers as Defence Against SARS-COV2. ClinicalTrials.gov."},{"key":"e_1_3_7_48_1","unstructured":"Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19. ClinicalTrials.gov."},{"key":"e_1_3_7_49_1","unstructured":"EudraCT Number 2020-001591-15. EU Clinical Trials Register."},{"key":"e_1_3_7_50_1","unstructured":"Performance Evaluation of BCG vs COVID-19. ClinicalTrials.gov."},{"key":"e_1_3_7_51_1","unstructured":"COVID-19: BCG As Therapeutic Vaccine Transmission Limitation and Immunoglobulin Enhancement - Full Text View - ClinicalTrials.gov. US National Library of Medicine National Institutes of Health. clinicaltrials.gov."},{"key":"e_1_3_7_52_1","unstructured":"EudraCT Number 2020-001678-31. EU clinical trials register. EU."},{"key":"e_1_3_7_53_1","unstructured":"Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic - Full Text View - ClinicalTrials.gov. US National Library of Medicine National Institutes of Health. clinicaltrials.gov"},{"key":"e_1_3_7_54_1","unstructured":"WHO. Bacille Calmette-Gu\u00e9rin (BCG) vaccination and COVID-19-Scientific Brief. 2020."},{"key":"e_1_3_7_55_1","unstructured":"https:\/\/www.who.int\/news-room\/commentaries\/detail\/bacille-calmette-gu%C3%A9rin-(bcg)-vaccination-and-covid-19"},{"key":"e_1_3_7_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106717"},{"key":"e_1_3_7_57_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc6284"},{"key":"e_1_3_7_58_1","unstructured":"Liu A. China\u2019s CanSino Bio advances COVID-19 vaccine into phase 2 on preliminary safety data. FiercePharma. 2020. Accessed 13 April 2020. \u201c\u2018CanSino and its collaborators at the Academy of Military Medical Sciences\u2019 Institute of Biotechnology plan to move their adenovirus type-5 vector-based recombinant COVID-19 vaccine Ad5-nCoV into phase 2 clinical trial in China \u201csoon\u201d \u2019 the company said in a disclosure (PDF) to the Hong Kong Stock Exchange on Thursday. Archived from the original on 30 April 2020."},{"key":"e_1_3_7_59_1","unstructured":"Clinical trial number NCT04341389 for \u201cA Phase II Clinical Trial to Evaluate the Recombinant Novel Coronavirus Vaccine (Adenovirus Vector) at ClinicalTrials.gov."},{"key":"e_1_3_7_60_1","unstructured":"Clinical trial number NCT04313127 for \u201cA Phase I Clinical Trial in 18-60 Adults at clinicalTrials.gov."},{"key":"e_1_3_7_61_1","unstructured":"EudraCT Number 2020-001038-36. EU Clinical Trials Register. European Union."},{"key":"e_1_3_7_62_1","unstructured":"Clinical trial number NCT04324606 for A Study of a Candidate COVID-19 Vaccine (COV001) at ClinicalTrials.gov."},{"key":"e_1_3_7_63_1","unstructured":"Clinical trial number NCT04444674 for A Study of a Candidate COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African adults with and without HIV-infection at ClinicalTrials.gov."},{"key":"e_1_3_7_64_1","unstructured":"University of Oxford commences clinical trial for vaccine candidate (ChAdOx1 nCoV-19) Targeting COVID-19. Trial Site News. 31 March 2020."},{"key":"e_1_3_7_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31604-4"},{"key":"e_1_3_7_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30266-X"},{"key":"e_1_3_7_67_1","unstructured":"Clinical trial number NCT04336410 for Safety Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers at ClinicalTrials.gov."},{"key":"e_1_3_7_68_1","unstructured":"IVI INOVIO and KNIH to partner with CEPI in a Phase I\/II clinical trial of INOVIO\u2019s COVID-19 DNA vaccine in South Korea. International Vaccine Institute. 16 April 2020."},{"key":"e_1_3_7_69_1","unstructured":"NIH clinical trial of investigational vaccine for COVID-19 begins. US national institutes of health. 16 March 2020."},{"key":"e_1_3_7_70_1","unstructured":"Clinical trial number NCT04283461 for Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis SARS CoV-2 Infection at ClinicalTrials.gov."},{"key":"e_1_3_7_71_1","unstructured":"Clinical trial number NCT04299724 for Safety and Immunity of Covid-19 aAPC Vaccine at ClinicalTrials.gov."},{"key":"e_1_3_7_72_1","unstructured":"Clinical trial number NCT04276896 for Immunity and Safety of Covid-19 Synthetic Minigene Vaccine at ClinicalTrials.gov."},{"key":"e_1_3_7_73_1","unstructured":"Clinical trial number NCT04334980 for Evaluating the Safety Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19 at ClinicalTrials.gov. US National Library of Medicine NIH."},{"key":"e_1_3_7_74_1","unstructured":"Clinical trial number NCT04352608 for Safety and Immunogenicity Study of 2019-nCoV Vaccine (Inactivated) for Prophylaxis SARS CoV-2 Infection (COVID-19) at ClinicalTrials.gov."},{"key":"e_1_3_7_75_1","unstructured":"A randomized double-blind placebo parallel-controlled phase I\/II clinical trial for inactivated novel coronavirus pneumonia vaccine (Vero cells)\u201d. Chinese Clinical Trial Registry. April 2020"},{"key":"e_1_3_7_76_1","unstructured":"hyFc platform. [Accessed 2020 Apr 30]. http:\/\/www.genexine.com\/m21.php"},{"key":"e_1_3_7_77_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00534-14"},{"key":"e_1_3_7_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2012.09.001"},{"key":"e_1_3_7_79_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.5.2925"},{"key":"e_1_3_7_80_1","doi-asserted-by":"publisher","DOI":"10.4110\/in.2017.17.5.343"},{"key":"e_1_3_7_81_1","doi-asserted-by":"publisher","DOI":"10.1089\/088282403763635465"},{"key":"e_1_3_7_82_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00597"},{"key":"e_1_3_7_83_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02015-19"},{"key":"e_1_3_7_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.07.090"},{"key":"e_1_3_7_85_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000003"},{"key":"e_1_3_7_86_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2012-7"},{"key":"e_1_3_7_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00546-6"},{"key":"e_1_3_7_88_1","unstructured":"CEPI. Our vaccine and platform portfolio. Coalition for Epidemic Preparedness Innovation (CEPI). 30 April 2020."},{"key":"e_1_3_7_89_1","unstructured":"CEPI collaborates with the Institute Pasteur in a consortium to develop COVID-19 vaccine. Coalition for Epidemic Preparedness Innovations. 19 March 2020"},{"key":"e_1_3_7_90_1","unstructured":"Yeung J. Millions of chickens are used to make vaccines each year. But that won\u2019t work for coronavirus. CNN. 2020."},{"key":"e_1_3_7_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2016.01.012"},{"key":"e_1_3_7_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.05.002"},{"key":"e_1_3_7_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30346-2"},{"key":"e_1_3_7_94_1","unstructured":"Strovel J Sittampalam S Coussens NP Hughes M Inglese J Kurtz A Andalibi A Patton L Austin C Baltezor M et al. Early drug discovery and development guidelines: for academic researchers collaborators and start-up companies. In: Markossian Sittampalam S editors. Assay guidance manual [Internet]. Eli Lilly & Company and the National Center for Advancing Translational Sciences. National Institute of Helth; 2020 (revised edition). p. 3\u201337."},{"key":"e_1_3_7_95_1","unstructured":"WHO. Public statement for collaboration on COVID-19 vaccine development. World Health Organization. 13 April 2020"},{"key":"e_1_3_7_96_1","unstructured":"Jef A. COVID-19 vaccine frontrunners. The Scientist Magazine April 7 2020."}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2020.1865774","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T18:37:14Z","timestamp":1744051034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2020.1865774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,5]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,31]]}},"alternative-id":["10.1080\/21645515.2020.1865774"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2020.1865774","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"type":"print","value":"2164-5515"},{"type":"electronic","value":"2164-554X"}],"subject":[],"published":{"date-parts":[[2021,2,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-05-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"1865774"}}